Procter & Gamble Health Ltd (PROR)

Currency in INR
5,927.50
-14.60(-0.25%)
Delayed Data·
PROR Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
PROR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5,918.605,956.00
52 wk Range
4,912.306,107.55
Key Statistics
Bid/Ask
5,917.05 / 5,932.75
Prev. Close
5,942.1
Open
5,942.1
Day's Range
5,918.6-5,956
52 wk Range
4,912.3-6,107.55
Volume
378
Average Volume (3m)
637
1-Year Change
14.82%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PROR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Procter & Gamble Health Ltd Company Profile

Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.

Employees
1336
Market
India

Compare PROR to Peers and Sector

Metrics to compare
PROR
Peers
Sector
Relationship
P/E Ratio
39.3x36.6x−0.5x
PEG Ratio
2.240.870.00
Price/Book
18.4x4.7x2.6x
Price / LTM Sales
8.1x4.6x3.2x
Upside (Analyst Target)
-7.8%42.0%
Fair Value Upside
Unlock−3.7%6.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 151.33%
Dividend Yield
3.11%
Industry Median 0.73%
Annualised payout
185.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 29, 2025
EPS / Forecast
36.86 / --
Revenue / Forecast
3.14B / --
EPS Revisions
Last 90 days

PROR Income Statement

People Also Watch

242.23
BOB
-0.01%
14,500.00
SLIN
+0.20%
7,436.50
APLH
-0.26%
5,508.00
ABB
-1.27%
5,093.00
LTIM
+0.72%

FAQ

What Stock Exchange Does Procter & Gamble Health Ltd Trade On?

Procter & Gamble Health Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Procter & Gamble Health Ltd?

The stock symbol for Procter & Gamble Health Ltd is "PROR."

What Is the Procter & Gamble Health Ltd Market Cap?

As of today, Procter & Gamble Health Ltd market cap is 98.31B.

What Is Procter & Gamble Health Ltd's Earnings Per Share (TTM)?

The Procter & Gamble Health Ltd EPS (TTM) is 151.33.

When Is the Next Procter & Gamble Health Ltd Earnings Date?

Procter & Gamble Health Ltd will release its next earnings report on 19 Aug 2025.

From a Technical Analysis Perspective, Is PROR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Procter & Gamble Health Ltd Stock Split?

Procter & Gamble Health Ltd has split 0 times.

How Many Employees Does Procter & Gamble Health Ltd Have?

Procter & Gamble Health Ltd has 1336 employees.

What is the current trading status of Procter & Gamble Health Ltd (PROR)?

As of 30 Jul 2025, Procter & Gamble Health Ltd (PROR) is trading at a price of 5,927.50, with a previous close of 5,942.10. The stock has fluctuated within a day range of 5,918.60 to 5,956.00, while its 52-week range spans from 4,912.30 to 6,107.55.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.